In breast cancer, the combination of reduced CK8/18 expression, a basal-like phenotype and a relevant family history may suggest which tumors are associated with BRCA1 germline mutations, thus offering the possibility of simplified genetic testing (47). This evidence concerns the gene KRT8 and breast carcinoma.